Impact of 2020 SARS-CoV-2 outbreak on telemedicine management of cardiovascular disease in Italy
- PDF / 575,350 Bytes
- 6 Pages / 595.276 x 790.866 pts Page_size
- 72 Downloads / 136 Views
IM - ORIGINAL
Impact of 2020 SARS‑CoV‑2 outbreak on telemedicine management of cardiovascular disease in Italy Giuseppe Molinari1 · Natale Daniele Brunetti2 · Savina Nodari3 · Martina Molinari1 · Giampietro Spagna4 · Mariangela Ioakim5 · Giovanni Migliore6 · Vitangelo Dattoli7 · Ottavio Di Cillo8 Received: 28 May 2020 / Accepted: 5 November 2020 © The Author(s) 2020
Abstract The Covid-19 pandemic affected large part of Italy since February 2020; we, therefore, aimed to assess the impact of 2020 SARS-CoV-2 outbreak on telemedicine management of cardiovascular disease (CVD) in Italy. We analyzed data from three telemedicine dispatch centers, one located in Genoa, serving private clients (pharmacies, general practitioners), one in Brescia, serving pharmacies, and one in Bari, serving regional public STEMI network and emergency medical service in Apulia (4 million inhabitants). Demographic data and principal electrocardiogram diagnosis were collected and analyzed. Records from the time interval March 1, 2020 and April 1, 2020 were compared with the corresponding period in 2019. The comparative analysis of data shows a 54% reduction of telemedicine electrocardiogram transmission in Genoa telemedicine center (from 364 to 166), 68% in Brescia (from 5.745 to 1.905), 24% in Bari (from 15.825 to 11.716); relative reduction according to electrocardiogram diagnosis was 38% for acute coronary syndrome, 40% for other acute CVD in Genoa center, 24% for acute coronary syndrome, and 38% for other acute CVD in Bari. Male/female ratio remained substantially unchanged. A dramatic reduction of telemedicine access for CVD was observed during Covid-19 outbreak in March 2020 in Italy. The reduction was substantially consistent for all electrocardiogram findings, ACS, other acute CVD and normal. Keywords Covid-19 · Telemedicine · Cardiovascular disease
* Natale Daniele Brunetti [email protected]
Ottavio Di Cillo [email protected]
Giuseppe Molinari [email protected]
1
“Telemedico Srl” Telecardiology Center, Genova, Italy
2
Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
3
Giampietro Spagna [email protected]
Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy
4
Cardiocalm Srl, Montichiari, BS, Italy
Mariangela Ioakim [email protected]
5
Policlinico Riuniti, Foggia, Italy
6
Policlinico Bari, Bari, Italy
7
Policlinico Riuniti, Foggia, Italy
8
Agenzia Regionale per la Salute e il Sociale, Bari, Italy
Savina Nodari [email protected] Martina Molinari [email protected]
Giovanni Migliore [email protected] Vitangelo Dattoli [email protected]
13
Vol.:(0123456789)
Introduction Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) is a positive-sense single-stranded RNA virus, responsible for the ongoing pandemic of Covid-19. The disease was first reported in Wuhan, China, but quickly spread out w
Data Loading...
